LAURIA, FRANCESCO
LAURIA, FRANCESCO
2-Chlorodeoxyadenosine in the treatment of relapsed/refractory chronic lymphoproliferative disorders.
1997-01-01 D., Rondelli; Lauria, Francesco; P. L., Zinzani; D., Raspadori; M. A., Ventura; P., Galieni; S., Birtolo; Forconi, Francesco; R., Algeri; S., Tura
A case of acute myelogenous leukemia: myelodysplastic syndrome with t(2;11)(p21;q23) without MLL rearrangement
2003-01-01 Gozzetti, Alessandro; Tozzuoli, Daniela; Crupi, Rosaria; Raspadori, Donatella; Fabbri, Alberto; Lauria, Francesco
A case of i(11)(q10) as sole cytogenetic abnormality in a patient with acute lymphoblastic leukemia.
2004-01-01 Gozzetti, A; Tozzuoli, D; Crupi, R; Bocchia, Monica; Mazzotta, S; Raspadori, D; Lauria, Francesco
A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): A case report.
2011-01-01 Gozzetti, A; Cerase, A; Crupi, R; Raspadori, D; Defina, M; Bocchia, Monica; Lauria, Francesco
A der(1)t(1;21)(p36.3;q22) in a patient with acute myelogenous leukemia M2
2010-01-01 Gozzetti, A; Crupi, R; Rondoni, M; Defina, M; Bocchia, Monica; Pietrini, A; Raspadori, D; Lauria, Francesco
A P210-derived multipeptide vaccine (CMLVAX100) induces reduction of “stable” minimal residual disease in chronic myeloid leukemia (CML) patients during treatment with Imatinib or alpha-Interferon
2003-01-01 Bocchia, Monica; Gentili, S; Abruzzese, E; Fanelli, A; Iuliano, F; Tabilio, A; Forconi, Francesco; Gozzetti, A; Raspadori, D; Amabile, M; Lauria, Francesco
A pilot monocentric analysis of efficacy and safety of Fludarabine-Campath combination (Flucam) as first line treatment in elderly patients with chronic lymphocytic leukaemia and Tp53 disfunction.
2011-01-01 Cencini, E.; Sozzi, E.; Sicuranza, A.; Fabbri, A.; Raspadori, D.; Lauria, Francesco; Forconi, Francesco
A t(20;21)(q12;q22.3) in a patient with chronic myelocytic leukemia in blastic phase [3]
2004-01-01 Gozzetti, Alessandro; Tozzuoli, Daniela; Crupi, Rosaria; Gentili, Sara; Raspadori, Donatella; Fabbri, Alberto; Lauria, Francesco
Absence of surface CD27 distinguishes hairy cell leukemia from other leukemic B-cell malignancies.
2005-01-01 Forconi, Francesco; D., Raspadori; M., Lenoci; Lauria, Francesco
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients
2006-01-01 Iacobucci, Ilaria; Saglio, Giuseppe; Rosti, Gianantonio; Testoni, Nicoletta; Pane, Fabrizio; Amabile, Marilina; Poerio, Angela; Soverini, Simona; Bassi, Simona; Cilloni, Daniela; Bassan, Renato; Breccia, Massimo; Lauria, Francesco; Izzo, Barbara; Merante, Serena; Frassoni, Francesco; Paolini, Stefania; Montefusco, Enrico; Baccarani, Michele; Martinelli, Giovanni; GIMEMA CML Working, Party; Bocchia, Monica
Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia
2006-01-01 Fabbri, Alberto; Gozzetti, Alessandro; Lazzi, Stefano; Lenoci, Mariapia; D'Amuri, Alessandro; Leoncini, Lorenzo; Lauria, Francesco
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma
1994-01-01 Zinzani, P L; Levrero, M G; Lauria, F; Rondelli, D; Zaja, F; Russo, D; Fanin, R; De Rossi, G; Mauro, F R; Bendandi, M; Gozzetti, A; Dianzani, F; Mandelli, F; Tura, S
Alternative methods of cladribine administration.
2011-01-01 Lauria, Francesco; E., Cencini; Forconi, Francesco
Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study
2010-01-01 Filì, Carla; Finelli, Carlo; Gobbi, Marco; Martinelli, Giovanni; Iacobucci, Ilaria; Ottaviani, Emanuela; Cocco, Lucio; Follo, Matilde; Candoni, Anna; Simeone, Erika; Miglino, Maurizio; Lauria, Francesco; Bocchia, Monica; Defina, Marzia; Clissa, Cristina; Lanza, Francesco; Curti, Antonio; Paolini, Stefania; Spedini, Pierangelo; Skert, Cristina; Bergonzi, Cesare; Malagola, Michele; Peli, Annalisa; Turra, Alessandro; Cattina, Federica; Colombi, Chiara; Russo, Domenico
BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial.
2009-01-01 Bocchia, Monica; Defina, M; Ippoliti, M; Amabile, M; Breccia, M; Iuliano, F; Vignetti, M; Gugliotta, G; RUSSO ROSSI, A; Alimena, A; Aprile, Lara; Gaidano, G; Nicoli, N; Trawinska, Mm; Bassan, R; Turri, D; Cannella, L; Luciano, L; Gozzetti, A; Rondoni, M; Rosti, G; Martinelli, G; Baccarani, M; Lauria, Francesco
Bcr-abl peptides for chronic myeloid leukemia.
2005-01-01 Bocchia, Monica; Ippoliti, M; Pirrotta, M. T.; Abruzzese, E; Trawinska, M. M.; Forconi, Francesco; Gozzetti, A; Raspadori, D; Lauria, Francesco
Case-control study of multidrug resistance phenotype and response to induction treatment includine or not fludarabine in newly diagnosed acute myeloid leukemia patients.
2007-01-01 Malagola, M; Damiani, D; Martinelli, G; Michelutti, A; Cesana, B; DE VIVO, A; Leoncini, L; Ottaviani, E; Candoni, A; Geronim, A; Tiribelli, M; Fanin, R; Testoni, N; Lauria, F; Bocchia, M.; Gobbi, M; Pierri, I; Zaccaria, A; Zuffa, E; Mazza, P; Piccolo, G; Gugliotta, L; Bovini, Beatrice; Visani, G; Skert, C; Gergonzi, C; Roccaro, Am; Fili, C; Baccarani, M; Russo, D
CD30 positive (non-anaplastic) peripheral T-cell lymphoma of the thyroid gland.
1999-01-01 Forconi, Francesco; Bocchia, Monica; S., Marconcini; C., Bigazzi; M., Milani; G., Fraternali Orcioni; Lauria, Francesco
CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate
2008-01-01 Bocchia, Monica; Ippoliti, M; Gozzetti, A; Abruzzese, E; Calabrese, S; Amabile, M; Pirrotta, Mt; Crupi, R; Tozzuoli, D; Trawinska, Mm; Defina, M; Martinelli, G; Lauria, Francesco
CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome
2002-01-01 Raspadori, Donatella; Damiani, Daniela; Michieli, Mariagrazia; Stocchi, Raffaella; Gentili, Sara; Gozzetti, Alessandro; Masolini, Paola; Michelutti, Angela; Geromin, Antonella; Fanin, Renato; Lauria, Francesco
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| 2-Chlorodeoxyadenosine in the treatment of relapsed/refractory chronic lymphoproliferative disorders. | 1-gen-1997 | D., Rondelli; Lauria, Francesco; P. L., Zinzani; D., Raspadori; M. A., Ventura; P., Galieni; S., Birtolo; Forconi, Francesco; R., Algeri; S., Tura | - | |
| A case of acute myelogenous leukemia: myelodysplastic syndrome with t(2;11)(p21;q23) without MLL rearrangement | 1-gen-2003 | Gozzetti, Alessandro; Tozzuoli, Daniela; Crupi, Rosaria; Raspadori, Donatella; Fabbri, Alberto; Lauria, Francesco | - | |
| A case of i(11)(q10) as sole cytogenetic abnormality in a patient with acute lymphoblastic leukemia. | 1-gen-2004 | Gozzetti, A; Tozzuoli, D; Crupi, R; Bocchia, Monica; Mazzotta, S; Raspadori, D; Lauria, Francesco | - | |
| A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): A case report. | 1-gen-2011 | Gozzetti, A; Cerase, A; Crupi, R; Raspadori, D; Defina, M; Bocchia, Monica; Lauria, Francesco | - | |
| A der(1)t(1;21)(p36.3;q22) in a patient with acute myelogenous leukemia M2 | 1-gen-2010 | Gozzetti, A; Crupi, R; Rondoni, M; Defina, M; Bocchia, Monica; Pietrini, A; Raspadori, D; Lauria, Francesco | - | |
| A P210-derived multipeptide vaccine (CMLVAX100) induces reduction of “stable” minimal residual disease in chronic myeloid leukemia (CML) patients during treatment with Imatinib or alpha-Interferon | 1-gen-2003 | Bocchia, Monica; Gentili, S; Abruzzese, E; Fanelli, A; Iuliano, F; Tabilio, A; Forconi, Francesco; Gozzetti, A; Raspadori, D; Amabile, M; Lauria, Francesco | - | |
| A pilot monocentric analysis of efficacy and safety of Fludarabine-Campath combination (Flucam) as first line treatment in elderly patients with chronic lymphocytic leukaemia and Tp53 disfunction. | 1-gen-2011 | Cencini, E.; Sozzi, E.; Sicuranza, A.; Fabbri, A.; Raspadori, D.; Lauria, Francesco; Forconi, Francesco | - | |
| A t(20;21)(q12;q22.3) in a patient with chronic myelocytic leukemia in blastic phase [3] | 1-gen-2004 | Gozzetti, Alessandro; Tozzuoli, Daniela; Crupi, Rosaria; Gentili, Sara; Raspadori, Donatella; Fabbri, Alberto; Lauria, Francesco | - | |
| Absence of surface CD27 distinguishes hairy cell leukemia from other leukemic B-cell malignancies. | 1-gen-2005 | Forconi, Francesco; D., Raspadori; M., Lenoci; Lauria, Francesco | - | |
| Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients | 1-gen-2006 | Iacobucci, Ilaria; Saglio, Giuseppe; Rosti, Gianantonio; Testoni, Nicoletta; Pane, Fabrizio; Amabile, Marilina; Poerio, Angela; Soverini, Simona; Bassi, Simona; Cilloni, Daniela; Bassan, Renato; Breccia, Massimo; Lauria, Francesco; Izzo, Barbara; Merante, Serena; Frassoni, Francesco; Paolini, Stefania; Montefusco, Enrico; Baccarani, Michele; Martinelli, Giovanni; GIMEMA CML Working, Party; Bocchia, Monica | - | |
| Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia | 1-gen-2006 | Fabbri, Alberto; Gozzetti, Alessandro; Lazzi, Stefano; Lenoci, Mariapia; D'Amuri, Alessandro; Leoncini, Lorenzo; Lauria, Francesco | - | |
| Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma | 1-gen-1994 | Zinzani, P L; Levrero, M G; Lauria, F; Rondelli, D; Zaja, F; Russo, D; Fanin, R; De Rossi, G; Mauro, F R; Bendandi, M; Gozzetti, A; Dianzani, F; Mandelli, F; Tura, S | - | |
| Alternative methods of cladribine administration. | 1-gen-2011 | Lauria, Francesco; E., Cencini; Forconi, Francesco | - | |
| Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study | 1-gen-2010 | Filì, Carla; Finelli, Carlo; Gobbi, Marco; Martinelli, Giovanni; Iacobucci, Ilaria; Ottaviani, Emanuela; Cocco, Lucio; Follo, Matilde; Candoni, Anna; Simeone, Erika; Miglino, Maurizio; Lauria, Francesco; Bocchia, Monica; Defina, Marzia; Clissa, Cristina; Lanza, Francesco; Curti, Antonio; Paolini, Stefania; Spedini, Pierangelo; Skert, Cristina; Bergonzi, Cesare; Malagola, Michele; Peli, Annalisa; Turra, Alessandro; Cattina, Federica; Colombi, Chiara; Russo, Domenico | - | |
| BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial. | 1-gen-2009 | Bocchia, Monica; Defina, M; Ippoliti, M; Amabile, M; Breccia, M; Iuliano, F; Vignetti, M; Gugliotta, G; RUSSO ROSSI, A; Alimena, A; Aprile, Lara; Gaidano, G; Nicoli, N; Trawinska, Mm; Bassan, R; Turri, D; Cannella, L; Luciano, L; Gozzetti, A; Rondoni, M; Rosti, G; Martinelli, G; Baccarani, M; Lauria, Francesco | - | |
| Bcr-abl peptides for chronic myeloid leukemia. | 1-gen-2005 | Bocchia, Monica; Ippoliti, M; Pirrotta, M. T.; Abruzzese, E; Trawinska, M. M.; Forconi, Francesco; Gozzetti, A; Raspadori, D; Lauria, Francesco | - | |
| Case-control study of multidrug resistance phenotype and response to induction treatment includine or not fludarabine in newly diagnosed acute myeloid leukemia patients. | 1-gen-2007 | Malagola, M; Damiani, D; Martinelli, G; Michelutti, A; Cesana, B; DE VIVO, A; Leoncini, L; Ottaviani, E; Candoni, A; Geronim, A; Tiribelli, M; Fanin, R; Testoni, N; Lauria, F; Bocchia, M.; Gobbi, M; Pierri, I; Zaccaria, A; Zuffa, E; Mazza, P; Piccolo, G; Gugliotta, L; Bovini, Beatrice; Visani, G; Skert, C; Gergonzi, C; Roccaro, Am; Fili, C; Baccarani, M; Russo, D | - | |
| CD30 positive (non-anaplastic) peripheral T-cell lymphoma of the thyroid gland. | 1-gen-1999 | Forconi, Francesco; Bocchia, Monica; S., Marconcini; C., Bigazzi; M., Milani; G., Fraternali Orcioni; Lauria, Francesco | - | |
| CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate | 1-gen-2008 | Bocchia, Monica; Ippoliti, M; Gozzetti, A; Abruzzese, E; Calabrese, S; Amabile, M; Pirrotta, Mt; Crupi, R; Tozzuoli, D; Trawinska, Mm; Defina, M; Martinelli, G; Lauria, Francesco | - | |
| CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome | 1-gen-2002 | Raspadori, Donatella; Damiani, Daniela; Michieli, Mariagrazia; Stocchi, Raffaella; Gentili, Sara; Gozzetti, Alessandro; Masolini, Paola; Michelutti, Angela; Geromin, Antonella; Fanin, Renato; Lauria, Francesco | - |